Blending quality improvement and research methods for implementation science, Part II: Analysis of the quality of implementation

AACN Advanced Critical Care

Volumn 26, Issue 4, 2015, Pages 366-371

  Pokorney, Sean D ^a   Taft, Charles ^b   Granger, Bradi B ^c,d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ATRIAL FIBRILLATION; HEALTH SERVICES RESEARCH; HUMAN; METHODOLOGY; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TOTAL QUALITY MANAGEMENT;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; HEALTH SERVICES RESEARCH; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84945317726     PISSN: 15597768     EISSN: 15597776     Source Type: Journal    
DOI: 10.1097/NCI.0000000000000109     Document Type: Article

References (26)

1. Granger BB, Shah BR. Blending quality improvement and research methods for implementation science Part I: design and data collection. AACN Adv Crit Care. 2015; 26 (3):268-274.
2. Carroll C, Patterson M, Wood S, Booth A, Rick J, Balain S. A conceptual framework for implementation fidelity. Implementation Sci. 2007; 2: 40.
3. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implementation Sci. 2009; 4: 50.
4. Batalden PB, Davidoff F. What is "quality improvement" and how can it transform healthcare? Qual Saf Health Care. 2007; 16: 2-3.
5. Guinane CS, Sikes JI, Wilson RK. Using the PDSA cycle to standardize a quality assurance program in a quality improvement-driven environment. Jt Comm J Qual Improv.1994; 20 (12): 696-705.
6. Breslin SE, Hamilton KM, Paynter J. Deployment of lean six sigma in care coordination: an improved discharge process. Prof Case Manage. 2014; 19 (2): 77-83; quiz 4-5.
7. Leaphart CL, Gonwa TA, Mai ML, et al. Formal quality improvement curriculum and DMAIC method results in interdisciplinary collaboration and process improvement in renal transplant patients. J Surg Res. 2012; 177 (1): 7-13.
8. Pladevall M, Brotons C, Gabriel R, et al. Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation. 2010; 122 (12): 1183-1191.
9. Bosworth HB, Dubard CA, Ruppenkamp J, Trygstad T, Hewson DL, Jackson GL. Evaluation of a selfmanagement implementation intervention to improve hypertension control among patients in Medicaid. Transl Behav Med. 2011; 1 (1): 191-199.
10. January CT, Wann LS, Alpert JS, et al. AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64 (21): e1-e76.
11. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med. 1987; 147 (9): 1561.
12. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke. Neurology. 1978; 28 (10): 973.
13. Flegel K, Shipley M, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. The Lancet. 1987; 329 (8532): 526-529.
14. Hart RG, Pearce LA. Current status of stroke risk stratification in patients with atrial fibrillation. Stroke. 2009; 40 (7): 2607-2610.
15. Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation: the Framingham study. Stroke. 1996; 27 (10): 1760-1764.
16. Miyasaka Y, Barnes ME, Bailey KR, et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol. 2007; 49 (9): 986-992.
17. Wilke T, Groth A, Mueller S, et al. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183, 448 patients. Thromb Haemost. 2012; 107 (6): 1053-1065.
18. Hess CN, Broderick S, Piccini JP, et al. Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. Am Heart J. 2012; 164 (4): 607-615.
19. Partington SL, Abid S, Teo K, Oczkowski W, O'Donnell MJ. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy. Thromb Res. 2007; 120 (5): 663-669.
20. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and riskfactors in atrial fibrillation (ATRIA) study. Ann Intern Med.1999; 131 (12): 927-934.
21. Waldo AL, Becker RC, Tapson VF, Colgan KJ. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J AmColl Cardiol. 2005; 46 (9): 1729-1736.
22. Birman-Deych E, Radford MJ, Nilasena DS, Gage BF. Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation. Stroke. 2006; 37 (4): 1070-1074.
23. Walker AM, Bennett D. Epidemiology and outcomes in patients with atrial fibrillation in the United States. Heart Rhythm. 2008; 5 (10): 1365-1372.
24. Nieuwlaat R, Capucci A, Lip GY, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. EurHeart J. 2006; 27 (24): 3018-3026.
25. Lip GY. Preventing stroke in atrial fibrillation: the SPORTIF programme. Pathophysiol Haemost Thromb. 2005; 34 (suppl 1): 25-30.
26. Power M, Fogarty M, Madsen J, et al. Learning from the design and development of the NHS Safety Thermometer. Int J Qual Health Ca re. 2014; 26 (3): 287-297.